You are here

TU-8 Data Details

Expand All

TU-8 Increase comprehensive Medicaid insurance coverage of evidence-based treatment for nicotine dependency in States and the District of Columbia

About the Data: National

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

Data Source: 
State Tobacco Activities Tracking and Evaluation System (STATE); Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion (CDC/NCCDPHP)
Changed Since the Healthy People 2020 Launch: 
Yes
Measure: 
number
Baseline (Year): 
6 (2008)
Target: 
51
Target-Setting Method: 
Total coverage
Target-Setting Method Justification: 
The target is 51 so that all 50 states and District of Columbia cover all FDA-approved pharmacotherapies and recommended behavioral therapies (counseling). The 2008 Public Health Service Clinical Practice Guideline called upon all insurers, including Medicaid, to provide comprehensive coverage of effective treatments—both counseling and medication—without restrictions. To guarantee that all Medicaid enrollees have access to recommended tobacco-dependence treatments without barriers or limitations in Medicaid populations, comprehensive tobacco cessation benefits (medications and counseling) need to be included as part of the federally mandated core Medicaid benefit package.
Numerator: 

Number of States and the District of Columbia that provide the recommended full coverage of all tobacco-dependence treatments (FDA-approved medications and counseling) to help smokers quit.

Comparable Healthy People 2010 Objective: 
Adapted from HP2010 objective
Data Collection Frequency: 
Annual
Methodology Notes: 

    States providing the recommended full coverage of all tobacco-dependence treatments (FDA-approved medications and counseling) to help smokers quit are defined as having “Comprehensive Medicaid Coverage of Treatments.”

    The recommended full coverage of all tobacco-dependence treatments (FDA-approved medications and counseling) is defined as coverage of all of the following:

    • Medication coverage
      • Nicotine Patch
      • Nicotine Gum
      • Nicotine Lzenge
      • Nicotine Nasal Spray
      • Nicotine Inhaler
      • Varenicline (Chantix®)
      • Bupropion hydrochloride (Zyban®)
    • Counseling coverage
      • Group
      • Individual
      • Telephone (provided through state quitlines)

    In the STATE System, this is equivalent to a value of “Yes” in the “Summary” field for “Comprehensive Medicaid Coverage of Treatments.”

Changes Between HP2010 and HP2020: 
This objective is modified from Healthy People 2010 objective 27-08b. The Healthy People 2010 objective was, "Increase insurance coverage for evidence-based treatment for nicotine dependency: Medicaid programs in States and the District of Columbia" and was measured by the Health Policy Tracking Service; National Conference of State Legislators. For Healthy People 2020 the objective is, "Increase comprehensive Medicaid insurance coverage of evidence-based treatment for nicotine dependency in States and the District of Columbia" and the data source was changed to the State Medicaid Coverage for Tobacco Survey; CDC/ NCCPHP and University of California, Berkely, Center for Health and Public Policy Studies (Berkely, CHPPS).

About the Data: State

Description of the data source, numerator, denominator, survey questions, and other relevant details about the state-level data.

Data Source: 
State Tobacco Activities Tracking and Evaluation System (STATE); Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion (CDC/NCCDPHP)
Measure: 
number
Numerator: 

Number of States and the District of Columbia that provide the recommended full coverage of all tobacco-dependence treatments (FDA-approved medications and counseling) to help smokers quit.

Data Collection Frequency: 
Annual
Methodology Notes: 

      States providing the recommended full coverage of all tobacco-dependence treatments (FDA-approved medications and counseling) to help smokers quit are defined as having “Comprehensive Medicaid Coverage of Treatments.”

      The recommended full coverage of all tobacco-dependence treatments (FDA-approved medications and counseling) is defined as coverage of all of the following:

      • Medication coverage
        • Nicotine Patch
        • Nicotine Gum
        • Nicotine Lzenge
        • Nicotine Nasal Spray
        • Nicotine Inhaler
        • Varenicline (Chantix®)
        • Bupropion hydrochloride (Zyban®)
      • Counseling coverage
        • Group
        • Individual
        • Telephone (provided through state quitlines)

      In the STATE System, this is equivalent to a value of “Yes” in the “Summary” field for “Comprehensive Medicaid Coverage of Treatments.”

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch: 
In 2013 the data source was changed from the State Medicaid Coverage for Tobacco-Dependence Treatments; CDC/ NCCPHP and University of California, Berkely, Center for Health and Public Policy Studies (Berkely, CHPPS) to State Tobacco Activities Tracking and Evaluation System (STATE), CDC/NCCDPHP. As a result, the baseline year was revised from 2007 to 2008. The baseline and target values did not change.